FDA Office of Global Policy and Strategy (OGPS) Strategic Plan FY 2020–2024

The FDA Office Of Global Policy and Strategy (OGPS) Strategic Plan FY 2020–2024 is a national sectoral plan/strategy of the United States of America. Its main objectives are to foster partnerships and multilateral diplomacy; operate and maintain FDA’s foreign offices, including the policy planning and evaluation work associated with the foreign offices; and address issues related to the importation of FDA-regulated products.
More specifically, it aims to cultivate and maintain a successful organization and workforce; foster and support an inclusive and empowering organizational culture; attract and recruit highly skilled employees; develop and retain highly skilled employees; develop and document efficient processes, policies, and procedures to assure consistent practices; create opportunities for OGPS employees to increase cross-collaboration; assure policy actions are understood and promoted domestically and globally; promote policy coherence and mutual understanding across FDA Centers/Offices to advance public health priorities; assure alignment of the Agency’s strategic direction and policy actions with United States Government (USG) agencies; advance the Agency’s public health regulatory positions domestically and globally through effective advocacy; engage international stakeholders to promote FDA policies; strengthen policy alignment through engagement with stakeholders to support USG and FDA priorities; foster collaborative relationships with stakeholders to advance Agency priorities; advance the OGPS mission by collecting, analyzing, and sharing information and data; enhance risk-based strategies by gathering information; and exchange information with external stakeholders.